Calliditas Therapeutics AB American Depositary Shares
CALT
CALT was delisted on the 20th of September, 2024.
18 hedge funds and large institutions have $32.3M invested in Calliditas Therapeutics AB American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 6 closing their positions.
72% more capital invested
Capital invested by funds: $18.8M → $32.3M (+$13.5M)
5% less funds holding
Funds holding: 19 → 18 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
71% less call options, than puts
Call options by funds: $331K | Put options by funds: $1.13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Optiver Holding
Amsterdam,
Netherlands
|
+$544K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$296K |
| 3 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$165K |
| 4 |
GRP
Global Retirement Partners
San Rafael,
California
|
+$13.7K |
| 5 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$3.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.06M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$401K |
| 3 |
Morgan Stanley
New York
|
-$139K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$134K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$83.7K |
CALT Hedge Fund Activity: Q2 2024 in Review
18 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Calliditas Therapeutics AB American Depositary Shares (CALT) for Q2 2024, worth a combined $32.3M — up 72% from $18.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CALT and 5 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 3 added.
The largest buyer was Optiver Holding, adding an estimated $544K. The largest seller was Deutsche Bank, exiting entirely with an estimated $1.06M sold.
- 18 institutional investors held Calliditas Therapeutics AB American Depositary Shares (CALT) as of Q2 2024, down from 19 in Q1 2024.
- Funds reported $32.3M of Calliditas Therapeutics AB American Depositary Shares stock for Q2 2024, up 72% quarter-over-quarter.
- 5 funds opened new Calliditas Therapeutics AB American Depositary Shares positions in Q2 2024 and 6 closed out, a net change of -1 holder.
- The largest Calliditas Therapeutics AB American Depositary Shares buyer in Q2 2024 was Optiver Holding, an estimated $544K added.
- The largest Calliditas Therapeutics AB American Depositary Shares seller in Q2 2024 was Deutsche Bank, an estimated $1.06M sold.
Based on aggregated 13F filings for Q2 2024.